Acrux Limited · ASX:ACR
Acrux — Investor Presentation (September 2021)
13 slides from Acrux's investor presentation, Sep 2, 2021
Slide 1: Acrux Investor Presentation
ACRUX INVESTOR PRESENTATION (ASX: ACR) September 2021
Slide 2: Important Notice and Disclaimers
IMPORTANT NOTICE AND DISCLAIMERS This presentation contains forward-looking statements which are identified by words such as ‘may’, ‘could’, ‘believes’, ‘estimates’, ‘expects’, or ‘intends’ and other similar words that involve risks and uncertainties. These statements are based on an assessment of p
Slide 3: Acrux track record in topical prescription pharmaceuticals
Acrux has a demonstrated track record of development and commercialisation of topical prescription pharmaceuticals Acrux has growing revenue from its product portfolio including revenue share, profit share and milestones Acrux has 3 products sold globally with a pipeline of 12 products in various st
Slide 4: Business overview
Business overview Acrux has a demonstrated track record of development and commercialisation of topical prescription pharmaceuticals Acrux product history Past Acrux outcomes Testosterone solution The product generated substantial Was sold in 6 countries with revenue share returns for Acrux shareh
Slide 5: Business overview
Business overview Acrux has growing revenue from its product portfolio including revenue share, profit share and milestones Acrux has 3 products sold globally with a pipeline of more than 12 products in various stages of development and 6 commercial partnerships in place Acrux product pipeline Recen
Slide 6: Key Investment highlights
Key Investment highlights 3 products on market in over 30 countries including Testosterone Topical solution launched in August 2021 in the United States Focus on specialised 15 topical generic products in portfolio including 12 in various stages of and lucrative topical development with an addre
Slide 7: Acrux is focussed on an underserved market segment
Acrux is focussed on an underserved market segment Acrux focus: Oral drugs Prescription topical drugs Total market Definition of market Drugs that are Drugs that are applied topically to the Total US prescription (all drugs including NCEs ingested orally skin, eyes, ears and nose pharma market and g
Slide 8: Revenue generating business model supporting long-term growth
Revenue generating business model supporting long-term growth 1 2 Product On market products are generating growing Generic drug development revenues for Acrux from growth of existing products identification and technology and new launches transfer to CMO Through the Acrux GMP facility with 25 s
Slide 9: FY21 Profit and Loss
FY21 Profit and Loss Profit and loss for the year ended 30 June 2021 2021 2020 Movement Movement $’000 $’000 $’000 % Revenue and Other Income Revenue from licensing agreements 1,337 1,253 84 7% R&D Tax Incentive Rebate 3,421 2,327 1,094 47% Other income 398 365 33 9% Total Revenue and Other Income 5
Slide 10: FY21 Cashflow
10 FY21 Cashflow 2021 2020 Movement $7000 $7000 $ Operating Activities Receipts from product agreements 1,228 1,093 135 R&D tax incentive rebate received 2,924 2,015 909 Other Income received 404 216 188 Payments to suppliers and employees (15,785) (11,666) (4,119) Finance costs (185) (191) 6 Net ca
Slide 11: Benefits of a Pooled Development Fund
BENEFITS OF A POOLED DEVELOPMENT FUND 1 Companies with PDF status are taxed at 15% on their income and capital gains received from their investments 2 Australian resident shareholders are exempt from capital gains tax after selling their shares 3 Unfranked dividends received by an Australian residen
Slide 12: Acrux Investment Opportunity
Acrux Investment Opportunity Track record of developing and launching products Increasing revenue from marketed products Extensive product pipeline under development FDA approval of 3 products in 2021 Additional product launches planned in 2022 Strong management team
Slide 13: Thank you
Thank you Michael Kotsanis CEO & Managing Director Acrux Limited P: + 61 3 8379 0100 E: michael.kotsanis@acrux.com.au Visit our website: http://www.acrux.com.au/ Follow us on LinkedIn: